IPGP insider sells 1,502 shares after exercising options on 10/07/2025
Rhea-AI Filing Summary
Director Eric Meurice reported option exercise and subsequent share sales in IPG Photonics Corp. (IPGP). On 10/07/2025 he exercised 1,502 director stock options at an exercise price of $87.87 per share, receiving 1,502 shares. Following that, he sold a total of 1,502 shares in two blocks: 674 shares sold at a weighted average price of $89.24 and 828 shares sold at a weighted average price of $90.01, reducing his beneficial ownership to 22,803 shares held directly. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on 03/07/2025. The reporting was signed by an attorney-in-fact on 10/08/2025. The filing shows routine management liquidity from option exercise and plan-driven dispositions, with all transactions disclosed at their execution prices.
Positive
- Transactions disclosed transparently with prices, volumes, and plan adoption date
- Sales executed under a Rule 10b5-1 plan, providing procedural compliance and affirmative defense
Negative
- Director's direct ownership decreased to 22,803 shares after the transactions
- Sales occurred immediately after option exercise, showing near-term monetization of equity
Insights
TL;DR: Director exercised 1,502 options and sold the resulting shares under a 10b5-1 plan on 10/07/2025.
The director exercised vested stock options at an exercise price of $87.87 to acquire 1,502 shares and then sold those shares in two tranches at weighted average prices of $89.24 and $90.01. The sales were carried out under a written Rule 10b5-1 plan adopted on 03/07/2025, which provides an affirmative defense against insider trading claims if properly structured.
The main dependency is the documented 10b5-1 plan timing and execution; the filing includes statements that the sales were pursuant to that plan. Investors may note the near-term liquidity event reduced direct holdings to 22,803 shares; this is a routine insider monetization rather than a change in control or compensation structure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (right to buy) | 1,502 | $0.00 | -- |
| Exercise | Common Stock | 1,502 | $87.87 | $132K |
| Sale | Common Stock | 674 | $89.24 | $60K |
| Sale | Common Stock | 828 | $90.01 | $75K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2025. The reported transaction involves sale transactions ranging from $88.87 to $89.62 per share. The weighted average price per share was $89.24. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. The reported transaction involves sale transactions ranging from $89.96 to $90.11 per share. The weighted average price per share was $90.01. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. Grant of stock options vesting 100% on earlier of 6/1/2017 or date of 2017 annual stockholder meeting of Issuer.
